Health Care & Life Sciences » Pharmaceuticals | Kukje Pharma Co. Ltd.

Kukje Pharma Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
899
634
868
6,678
3,462
3,865
Total Accounts Receivable
47,348
45,747
44,606
35,725
38,240
36,223
Inventories
21,752
25,138
20,167
17,867
17,162
14,184
Other Current Assets
313
395
1,115
168
673
287
Total Current Assets
70,312
71,913
66,756
60,438
59,537
54,559
Net Property, Plant & Equipment
37,313
36,057
61,944
60,130
60,645
61,277
Total Investments and Advances
6,289
6,758
7,386
6,877
8,114
5,384
Long-Term Note Receivable
327
458
-
-
-
3,141
Intangible Assets
1,025
761
756
1,380
2,793
1,873
Other Assets
681
-
-
631
557
-
Total Assets
117,431
117,508
138,370
131,720
134,762
130,126
ST Debt & Current Portion LT Debt
10,553
28,367
13,361
31,090
30,500
Accounts Payable
12,322
13,810
9,517
11,111
11,483
Income Tax Payable
-
-
961
777
844
Other Current Liabilities
8,212
13,383
8,198
6,953
7,750
Total Current Liabilities
31,087
55,560
32,037
49,932
50,577
Long-Term Debt
24,250
7,000
27,000
2,000
4,000
Provision for Risks & Charges
2,636
2,961
2,401
3,754
3,437
Deferred Taxes
1,483
1,561
6,012
5,318
4,989
Other Liabilities
1,129
1,135
933
933
865
Total Liabilities
59,102
66,655
69,911
64,201
66,984
Common Equity (Total)
58,295
50,795
68,263
67,504
67,743
Total Shareholders' Equity
58,295
50,795
68,263
67,504
67,743
Total Equity
58,329
50,853
68,459
67,519
67,778
Liabilities & Shareholders' Equity
117,431
117,508
138,370
131,720
134,762
Accumulated Minority Interest
34
58
196
16
35

About Kukje Pharma Co.

View Profile
Address
96-8 Yatap-ro
Seongnam-si GY 13517
Korea, Republic Of
Employees -
Website http://www.kukjepharm.co.kr
Updated 07/08/2019
KUKJE PHARMA Co. Ltd. engages in the manufacture, sale and distribution of pharmaceutical, cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antibiotics, and antifungal and antiviral agents. The company was founded on July 27, 1959 and is headquartered in Seongnam-si, South Korea.